<DOC>
	<DOCNO>NCT01131767</DOCNO>
	<brief_summary>The purpose study assess bioequivalence Naproxen sodium 220 mg + Pseudoephedrine Hydrochloride 120 mg Extended Release tablet Aleve Cold Sinus healthy adult human subject , fed condition .</brief_summary>
	<brief_title>Bioequivalence Study Naproxen Sodium 220 mg &amp; Pseudoephedrine HCl 120 mg ER Tablets Dr. Reddy 's Under Fed Conditions</brief_title>
	<detailed_description>Open randomize , two treatment , two period , two sequence , single dose , crossover study 26 healthy human adult subject feed condition washout period 27 day .</detailed_description>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<criteria>Subjects must fulfill follow criterion consider inclusion study : Subjects provide write informed consent . Subjects must healthy human being within 1845 year age ( inclusive ) weigh least 50 kg . Subjects must within Â±15 % ideal body weight relation height accord Life Insurance Corporation India heightweight chart non medical case . Subjects must normal health determine medical history physical examination perform within 21 day prior commencement study . Have normal ECG , Xray vital sign . Availability subject entire study period willingness adhere protocol requirement evidence write informed consent . If subject female volunteer Is child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly . diaphragm , intrauterine device ( IUD ) , abstinence . Is postmenopausal least 1 year . Is surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject . The subject exclude follow condition : History presence significant : Cardiovascular , pulmonary , hepatic , renal , hematological , gastrointestinal , endocrine , immunologic , dermatologic , musculoskeletal , neurological psychiatric disease . Alcohol dependence , alcohol abuse drug abuse within past one year . Moderate heavy smoking ( &gt; 10 cigarettes/day ) consumption tobacco product . Asthma , urticaria allergic type reaction take medication . Subjects completion study , would donate excess 500 ml blood 14 day , 500 800ml blood 14 day ( unless approve Principal Investigator ) 1000 ml blood 90 day 1250 ml blood 120 day 1500 ml blood 180 day 2000 ml blood 270 day 2500 ml blood 1 year Subjects participate another clinical trial within 3 month study start . Subjects : Systolic blood pressure le 90 mm Hg high 150 mm Hg Diastolic blood pressure le 60 mm Hg 95 mm Hg . Minor deviation ( 13 mm Hg ) checkin may acceptable discretion physician/investigator . Pulse rate 50/min . 105/min . Female volunteer demonstrate positive pregnancy screen currently breastfeed .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Crossover</keyword>
	<keyword>Naproxen Sodium Pseudoephedrine Hydrochloride</keyword>
</DOC>